PRTN3 and rheumatoid arthritis: By contrast, among ACPA-negative RA patients, moderate or high MBDA scores were strongly associated with achieving sustained DMARD-free remission (moderate vs. low HR 9.40, 95% CI 1.21–72.85; high vs. low HR 9.73 95% CI 1.33–71.10).